Paclitaxel-coated Zilver PTX drug-eluting stent treatment does not result in increased long-term all-cause mortality compared to uncoated devices from Japan Post-Market Surveillance Study

1 September 2020 (10:55 - 11:01)
Organised by:
Congress Presentation Part of: Lower Extremity Artery Revascularization in 2020 Intervention ESC Premium Access ESC Congress 2020

ESC 365 is supported by

ESC 365 is supported by